The agriculture company said it will use the technology it has licensed for new applications in crop editing and for research to bring new foods to market.
The partners inked a licensing deal to market and distribute TGen's DeepChek-TB as a compact, portable, and affordable diagnostic model for physician use.
The biotech startup, which had been working with Cas12 and Cas13, has now licensed the recently discovered Cas14 protein from UC Berkeley.
CRISPR technology has made its way around the world, but in the wake of the He Jiankui controversy, the industry is asking what recourse it has against misuse.
Epigenomics terminated its collaboration with China's BioChain for the licensing of the septin9 marker and exclusive Chinese distribution rights for Epi proColon.
The license contains a new method and bioinformatic tools that improve detection in next-generation sequencing to help researchers identify rare gene variants.
The test uses qPCR to measure the methylation level of three bladder cancer-specific biomarkers in patient urine samples.
The companies have signed a licensing agreement related to bioinformatics tools to enable antimicrobial resistance research.
Promega said it will combine the CRISPR technology with its own products that are designed for knock-in of genetic reporters into cells or cell lines.
NimaGen said that it will use the technology to develop and market new kits and panels for next-generation sequencing.
Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.
Wired reports that researchers have shown they could reprogram a DNA-based computer.
Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.
In Science this week: whole-genome sequencing of single sperm cells, and more.